Tweets
What influences global scores to patients is different from physicians by Laura Coates #RNL2023 @RheumNow https://t.co/bTKozGeON6
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
3 years 3 months ago
Patients definition of remission in PsA, by Laura Coates #RNL2023 @RheumNow https://t.co/kphM14SH0E
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
3 years 3 months ago
#RNL2023
AGATA trial showed benefit of Abatecept in GCA - 48 to 31% disease free survival
Robert Spiera
@RheumNow https://t.co/pPzbdTTvEi
Eric Dein @ericdeinmd ( View Tweet )
3 years 3 months ago
#RNL2023
Rob Spiera: I often use aspirin a day, especially if cranial complications and no contra-indications"
No prospective studies, 2 large retrospective studies suggesting benefit
@RheumNow https://t.co/OedVG03yN3
Eric Dein @ericdeinmd ( View Tweet )
3 years 3 months ago
#RNL2023 Resources for pregnancy and lactation for patients on various #medications and #chronic #diseases. Have a look. Pregnant 🫃 #baby and #breast #feeding. https://t.co/A8zmBUAylG
Janet Pope @Janetbirdope ( View Tweet )
3 years 3 months ago
Is there role for MTX in GCA
Favorable results in a meta-analysis with NNT 11 to prevent 1 cranial relapse
BUT: limitations of meta-analysis, short follow-up, dose response not evaluated
Robert Spiera at #RNL2023 @RheumNow https://t.co/sHx2ceVmAi
Eric Dein @ericdeinmd ( View Tweet )
3 years 3 months ago
DMARDs/TNF for PMR:
MTX- initial benefit, but no 5 year steroid sparing effect
Infliximab - no benefit
Lef - some benefit in case series
Robert Spiera #RNL2023 @RheumNow https://t.co/cmwGEWHQEO
Eric Dein @ericdeinmd ( View Tweet )
3 years 3 months ago
IL-6 for PMR
SPARE and SEMAPORE (Toci), SAPHYR (Sari)
2/2023: FDA approves sarilumab for PMR for inadequate response to corticosteroids or unable to taper off
Robert Spiera @RheumNow #RNL2023 https://t.co/quOWjJjgB3
Eric Dein @ericdeinmd ( View Tweet )
3 years 3 months ago
Dr. Robert Spiera on Recent IL-6i in PMR treatment:
SPARE and SEMAPHORE study - Tocilizumab
SAPHYR - Sarilumab (now FDA approved for PMR tx)
@RheumNow #RNL2023 https://t.co/gofe54wSjo
Robert B Chao, MD @doctorRBC ( View Tweet )
3 years 3 months ago
SAPHYR, presented at #ACR22, unpublished
Robert Spiera at #RNL2023
Phase 3 study for refractory PMR
Sustained remission of disease, less steroids usage, steroid toxicity, and improved PROs
@RheumNow https://t.co/k3w2TQ3yEB
Eric Dein @ericdeinmd ( View Tweet )
3 years 3 months ago
@anisha_dua reviews considerations for your differential for PMR at #RNL2023 @RheumNow https://t.co/3ZsczB1UKH
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 3 months ago
I use US in my practice and since this data was presented last year, I’ve been evaluating subacromial/deltoid bursas my PMR patients. @anisha_dua reviews imaging at #RNL2023 @RheumNow https://t.co/1TYdXNmcx0
Dr. Rachel Tate @uptoTate ( View Tweet )
3 years 3 months ago
